Health-related Quality of Life in Rare Kidney Stone

Status Completed

Clinical Trial Summary

Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium

Clinical Trial Description

The purpose of this study is to learn about Health-related Quality Of Life (HRQoL) in patients enrolled in the Rare Kidney Stone Consortium (RKSC) registries. Quality of life studies look at different aspects of both physical and mental components of people's lives. HRQoL data for people affected by kidney stones are not currently available for people followed over time. ;

Study Design

Related Conditions & MeSH terms

Adenine Phosphoribosyl Transferase Deficiency
Cystinuria
Dent Disease
Hyperoxaluria, Primary
Kidney Calculi
Nephrolithiasis
Primary Hyperoxaluria

Clinical Trial Details

NCT number	NCT02124395
Study type	Observational [Patient Registry]
Source	NYU Langone Health
Contact
Status	Completed
Phase
Start date	August 2013
Completion date	July 2022

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00875823` - International Registry for Primary Hyperoxaluria	N/A
Recruiting	`NCT05687474` - Baby Detect : Genomic Newborn Screening
Completed	`NCT02340689` - Primary Hyperoxaluria Mutation Genotyping/Phenotyping
Completed	`NCT00638703` - Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients	Phase 2/Phase 3
Recruiting	`NCT06065852` - National Registry of Rare Kidney Diseases
Completed	`NCT03819647` - Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria	Phase 2
Recruiting	`NCT02026388` - Rare Kidney Stone Consortium Biobank
Completed	`NCT02000219` - Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis	Phase 2
Recruiting	`NCT05843851` - Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria	N/A
Recruiting	`NCT00588562` - Rare Kidney Stone Consortium Patient Registry
Completed	`NCT03391804` - Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia	Phase 2
Completed	`NCT03116685` - A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria	Phase 3
Recruiting	`NCT05107830` - Phenotyping of Primary Hyperoxaluria
Active, not recruiting	`NCT04152200` - A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1	Phase 3
Recruiting	`NCT05001269` - Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function	Phase 2
Completed	`NCT03392896` - Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria	Phase 1
Completed	`NCT02012985` - Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria	Phase 1/Phase 2
Completed	`NCT01037231` - Phase 2/3 Oxabact Study	Phase 2/Phase 3
Completed	`NCT00589225` - Primary Hyperoxaluria Mutation Genotyping	Phase 1
Completed	`NCT03350451` - An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1	Phase 2